Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."


TSX:MSL - Post by User

Comment by lscfaon Dec 14, 2016 9:57am
273 Views
Post# 25597465

RE:RE:Q4 on sedar.com

RE:RE:Q4 on sedar.comI have told these guys to stop using EBITDA for guidance (or at least supplement it with other measures) because it does not reflect the low tax rate and low interest rate they have.....

Ev = 8x 2016 adjusted EBITDA $43 mil = $344 mil
Share value = ($344 mil - $145 mil debt) / 111 mil shs. = $1.79 per SH.

vs.

eps of $0.25 x 12 p/e = $3.00
<< Previous
Bullboard Posts
Next >>